ArticleBMC cancer2019

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.

Farastuk Bozorgmehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.